Press Releases

Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis. Shimadzu launched its new Nexera XS inert, a bioinert and biocompatible ultra-high performance liquid chromatograph (UHPLC), in July 2022. The system is designed to...

Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status. Roche launched its Elecsys HCV Duo immunoassay (Elecsys) in July 2022, which is the first available immunoassay...

AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and biopharmaceutical industry, announces the launch of its smart cable management system for cleanrooms – the AES OMNI™ Electric Utility Raceway. The OMNI™ Electric Utility Raceway is...

Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer. Merck, known as MSD outside the United States and Canada, announced a global development...

Pharmaceutical temperature-controlled specialist Tower Cold Chain has secured £6.75million in investment, to reinforce the business as the leader in robust, reliable, and reusable cold chain solutions, following a period of rapid and sustained growth. The investment, backed by Investec, comes...

Following the launch of their global collaboration to support medication adherence in different fields last year, Belgium-based AARDEX GROUP, the leader in tools for measuring and managing adherence to medication in clinical trials, and French-based BIOCORP, the leader in...

Privately-owned Grünenthal estimates the Nebido brand will add about €100 million to its EBITDA in 2023. Grünenthal has agreed to acquire testosterone treatment NebidoTM and its associated brands from Bayer AG, for up to €500 million. The long-acting injectable treatment for...